Document is current
Any future updates will be listed below
-
Authors
Montero-Odasso, Manuel http://orcid.org/0000-0002-5796-2361
Almeida, Quincy J.
Burhan, Amer M.
Camicioli, Richard
Doyon, Julien
Fraser, Sarah
Li, Karen
Liu-Ambrose, Teresa
Middleton, Laura
Muir-Hunter, Susan
McIlroy, William
Morais, José A.
Pieruccini-Faria, Frederico
Shoemaker, Kevin
Speechley, Mark
Vasudev, Akshya
Zou, G. Y.
Berryman, Nicolas
Lussier, Maxime
Vanderhaeghe, Leanne
Bherer, Louis
-
Funding
Funding for this research was provided by:
Canadian Consortium on Neurodegeneration in Aging (FRN CNA 137794)
- License Information
-
More Information
Article History
Received: 5 February 2018
Accepted: 3 April 2018
First Online: 16 April 2018
Ethics approval and consent to participate
: This study is conducted in compliance with International Conference on Harmonization Good Clinical Practice (ICH-GCP) and all applicable regulatory requirements. Sponsor site obtained approval of the Research Ethics Board at the University of Western Ontario (REB# 107670), the Lawson Health Research Institute’s Clinical Research Impact Committee (R-15-038), and Health Canada (HC file - HC6–24-c195918 / HC protocol #201619) prior to initiating study-related activities. Each intervention site has also obtained local ethical approval. Written consent to participate was obtained when participants signed the letter of information and consent. Capacity to consent was determined on the basis of direct observation of the participant and/or from information obtained from their family. Participants in this study do not have a degree of cognitive impairment (such as advanced dementia) that would prevent them from understanding the information given and appreciating the consequences of their decision.
: The authors declare they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
